UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines

European review for medical and pharmacological sciences, 2021-02, Vol.25 (3), p.1663

2021

Volltextzugriff (PDF)

Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

European review for medical and pharmacological sciences, 2020-04, Vol.24 (8), p.4539

2020

Volltextzugriff (PDF)

Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics

European review for medical and pharmacological sciences, 2021-12, Vol.25 (24), p.8012

2021

Volltextzugriff (PDF)

Human monkeypox outbreak: global prevalence and biological, epidemiological and clinical characteristics - observational analysis between 1970-2022

European review for medical and pharmacological sciences, 2022-08, Vol.26 (15), p.5624

2022

Volltextzugriff (PDF)

An economic analysis of interventions for diabetes

Diabetes care, 2000-03, Vol.23 (3), p.390-404

2000

Volltextzugriff (PDF)

Noninvasive blood glucose monitoring

Diabetes care, 1997-03, Vol.20 (3), p.433-437

Klonoff, D C

1997

Volltextzugriff (PDF)

Diabetes and technology in 2030: a utopian or dystopian future?

Diabetic medicine, 2018-04, Vol.35 (4), p.498-503

2018

Volltextzugriff (PDF)

Continuous Glucose Monitoring: Roadmap for 21st century diabetes therapy

Diabetes care, 2005-05, Vol.28 (5), p.1231-1239

Klonoff, David C

2005

Volltextzugriff (PDF)

Inhaled insulin

Diabetes technology & therapeutics, 1999, Vol.1 (3), p.307-313

Klonoff, D C

1999

Volltextzugriff (PDF)

A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.961-967

2019

Volltextzugriff (PDF)

Chronic Fatigue Syndrome

Clinical infectious diseases, 1992-11, Vol.15 (5), p.812-823

Klonoff, D C

1992

Volltextzugriff (PDF)

Hypoglycemia following inadvertent and factitious sulfonylurea overdosages

Diabetes care, 1995-04, Vol.18 (4), p.563-567

1995

Volltextzugriff (PDF)

Regulatory controversies surround blood glucose monitoring devices

Journal of diabetes science and technology, 2010-03, Vol.4 (2), p.231-235

Klonoff, David C

2010

Volltextzugriff (PDF)

Serum fructosamine as a screening test for type 2 diabetes

Diabetes technology & therapeutics, 2000, Vol.2 (4), p.537-539

Klonoff, D C

2000

Volltextzugriff (PDF)

Treatment of Painful Diabetic Neuropathy with 10 kHz Spinal Cord Stimulation: Long-Term Improvements in Hemoglobin A1c, Weight, and Sleep Accompany Pain Relief for People with Type 2 Diabetes

Journal of pain research, 2024-01, Vol.17, p.3063-3074

2024

Volltextzugriff (PDF)

Special funding boosts type 1 diabetes research

Diabetes technology & therapeutics, 2001, Vol.3 (2), p.282-282

Klonoff, D C

2001

Volltextzugriff (PDF)

FDA approves new glucose test for adult diabetics

Diabetes technology & therapeutics, 2001, Vol.3 (2), p.281-281

Klonoff, D C

2001

Volltextzugriff (PDF)

Allen M. Spiegel, M.D., named Director of NIDDK

Diabetes technology & therapeutics, 2000, Vol.2 (1), p.123-123

Klonoff, D C

2000

Volltextzugriff (PDF)

Clinical chemistry and clinical toxicology devices advisory panel recommendation on Glucowatch

Diabetes technology & therapeutics, 2000, Vol.2 (1), p.125

Klonoff, D C

2000

Volltextzugriff (PDF)

NIAID spearheads collaborative network for clinical research on immune tolerance

Diabetes technology & therapeutics, 2000, Vol.2 (1), p.124-125

Klonoff, D C

2000

Volltextzugriff (PDF)

The promise of optical sensing strategies for glucose

Diabetes technology & therapeutics, 1999, Vol.1 (4), p.401-402

Klonoff, D C

1999

Volltextzugriff (PDF)

New products and new technologies for diabetes

Diabetes technology & therapeutics, 1999, Vol.1 (3), p.237-238

Klonoff, D C

1999

Volltextzugriff (PDF)

Expressing the sense of the Senate to raise the awareness of the devastating impact of diabetes and to support increased funds for diabetes research

Diabetes technology & therapeutics, 1999, Vol.1 (4), p.525-527

Klonoff, D C

1999

Volltextzugriff (PDF)

Diabetes Prevention Program meets recruitment goals

Diabetes technology & therapeutics, 1999, Vol.1 (3), p.350-351

Klonoff, D C

1999

Volltextzugriff (PDF)

FDA approves new Glucose Monitoring System

Diabetes technology & therapeutics, 1999, Vol.1 (3), p.349-349

Klonoff, D C

1999

Volltextzugriff (PDF)

1 – 25 von 112

Menü

Weitere Dienste

Einstellungen

COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines

Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics

Human monkeypox outbreak: global prevalence and biological, epidemiological and clinical characteristics - observational analysis between 1970-2022

An economic analysis of interventions for diabetes

Noninvasive blood glucose monitoring

Diabetes and technology in 2030: a utopian or dystopian future?

Continuous Glucose Monitoring: Roadmap for 21st century diabetes therapy

Inhaled insulin

A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)

Chronic Fatigue Syndrome

Hypoglycemia following inadvertent and factitious sulfonylurea overdosages

Regulatory controversies surround blood glucose monitoring devices

Serum fructosamine as a screening test for type 2 diabetes

Treatment of Painful Diabetic Neuropathy with 10 kHz Spinal Cord Stimulation: Long-Term Improvements in Hemoglobin A1c, Weight, and Sleep Accompany Pain Relief for People with Type 2 Diabetes

Special funding boosts type 1 diabetes research

FDA approves new glucose test for adult diabetics

Allen M. Spiegel, M.D., named Director of NIDDK

Clinical chemistry and clinical toxicology devices advisory panel recommendation on Glucowatch

NIAID spearheads collaborative network for clinical research on immune tolerance

The promise of optical sensing strategies for glucose

New products and new technologies for diabetes

Expressing the sense of the Senate to raise the awareness of the devastating impact of diabetes and to support increased funds for diabetes research

Diabetes Prevention Program meets recruitment goals

FDA approves new Glucose Monitoring System

Suchergebnisse filtern